FDA Investigator LCDR Anastasia M Piliafas Brown
LCDR Anastasia M Piliafas Brown has conducted inspections on 60 sites in 1 countries as of 02 Jun 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
60
Last Inspection Date:
02 Jun 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with LCDR Anastasia M Piliafas Brown:
Alanna L Mussawwir Bias,
Amanda B Athey,
Amy N Chen,
Amy S Graf,
Andrew H Paeng,
Andrew J Garufi,
Andrew O Ejiofor,
Angela J Alexander,
Art O Czabaniuk,
Ashley L Reiber,
Ashley M Whitehurst,
Azza Talaat,
Barbara A Burke,
Barbara A Gullick,
Barbara A Rusin,
Barbara J Holladay,
Benjamin J Smith,
Bleta Vuniqi,
Brandon L Mariner,
Brian P Putz,
Brittany M Lowe,
Brooke K Higgins,
Brooke K Seeman,
Byungja E Marciante,
Calvin K Cook,
Carole L Jones,
Caroline H Le,
Catherine V Quinlan,
Chaltu Nwakijra,
Charles D Boison,
Charles E Idjagboro,
Charles M Kerns, BLT DO,
Charles M Spyr,
Christine W Twohy,
Clarice J Ahn,
Colleen F Hoyt,
Corrine M Carter,
Crystal M Young Lewis,
Cynthia A Harris, MD, RN,
Cynthia L Aycock,
Cynthia Li,
David J Gasparovich,
Deanna L Lampley,
Debara R Reese,
Diane T Bargo,
Diane T O'brien,
Edmund F Mrak, Jr,
Edward P Potter,
Edwin Melendez,
Emest F Bizjak,
Emily J Orban,
Eric S Pittman,
Erin L Mcfiren,
Erma Zaimova,
Frederick F Razzaghi,
Gail L Katz,
Gary Durbiel Goldner,
George G Calafactor,
Gerald D Bromley, Jr,
Gregory A Cronce,
James E Szelc,
James T Mccoy,
James W Leonette,
Jeanne D Shaffer,
Jennifer A Kemp,
John Dan,
Jonathan W Chapman,
Joseph R Strelnik,
Joseph W Matthews,
Judith A Jankowski,
Juliane C Lessard,
Justin H Price,
Keith M Reilly,
Kennita Riddick,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Krista N Flores,
L'oreal F Walker,
La Tasham Gunter,
Larry K Austin,
Laureen F Kononen,
Laureen M Geniusz,
Lauren E Burke,
Lauren E Sexton,
Laurissa S Flowers,
Linda S Mattingly,
Lori S Lawless,
LT Danielle S Mills,
LT Luis O Rodriguez,
LTJG Aaron B Otis,
Marcellinus D Dordunoo,
Margaret Torres Vazquez,
Marion W Nadeau,
Matthew J Gretkierewicz,
Matthew M Henciak,
Melissa J Garcia,
Merideth K Rose,
Michael K Larson,
Michele L Forster, PhD,
Mikhail V Ovanesov, PhD,
Mildred L Mccray,
Monica J Wilkins,
Monique Rac Lester,
Myra K Casey,
Nancy L Meade,
Neali H Lucas,
Nerizza B Guerin,
Nora S Orrell,
Norman Wong,
Paige E Shelborne,
Patricia A Morrow,
Patrick B Cummings,
Patsy J Domingo,
Paula J Bretz,
Rachel C Harrington,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Reginald Walker,
Robert J Doyle,
Ronald J Kozara,
Ronald T Nowalk,
Ryan J Benedict,
Sanket N Patel,
Sargum C Sood,
Sharon K Thoma, PharmD,
Sherri J Jackson,
Sherry L Secrist, BLT DO,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven J Thurber,
Steven P Donald,
Susan M North,
Suyang Qin,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Tamika E Allen, RN,
Teresa L Fox,
Thomas A Peter,
Tracey L Siebesma,
Twana R Chandler,
Vipulchandra N Dholakia,
Wanda Y Fields,
Wanda Y Honeyblue,
William D Tingley,
William G Nelson,
William J Leonard
LCDR Anastasia M Piliafas Brown's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2004 | FDA 483 | Hildenbrand International, Inc. DBA Osteo Concepts - Form 483, 2004-12-02 |
| June, 2006 | FDA 483 | Medtest Holdings, Inc. - Form 483, 2006-06-16 |
| November, 2004 | EIR | Aerosol & Liquid Packaging, Inc. - EIR, 2004-11-15 |
| November, 2004 | FDA 483 | Aerosol & Liquid Packaging, Inc. - Form 483, 2004-11-15 |
| August, 2008 | FDA 483 | Terumo Cardiovascular Systems Corporation - Form 483, 2008-08-12 |
| March, 2007 | FDA 483 | Roche Diagnostics Operations, Inc. - Form 483, 2007-03-09 |
| February, 2008 | FDA 483 | Lynn Medical Instrument Co. - Form 483, 2008-02-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more